Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Clinical trial NCT00590187 · COMPLETED
Trial details
- NCT number
- NCT00590187
- Sponsor
- Cyclacel Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.